German pharmaceutical giant Bayer raised its full-year earnings forecast as it reported a 13% rise in third-quarter net profit, boosted by strong growth in its health-care and crop-science divisions.
from WSJ.com: US Business http://ift.tt/102GDdD
via IFTTT
from WSJ.com: US Business http://ift.tt/102GDdD
via IFTTT
No comments:
Post a Comment